Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Findit who wrote (7746)	1/7/1998 1:25:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 14328

Could be some traders following the old adage "buy on rumor, sell on news". Today's action does not make a lot of sense from a fundimental perspective. But having lowered my cost substantially during the December sale, after we get some the qtr & annual statement, we'll start seing a marked improvement. And remember, with low EPS 1st & 2nd qtr 97, TRIBY should be able to put out some very good qtr press releases with great qtr over qtr comparisions. (I can visualze "Trinity Biotechnology announces first qtr results with record sales & revenues, 400% EPS growth. Thinking of EPS growth, with the sequence of .01 .01 .02 .03, plus the additional of new products/approvals, time for integration of operations from the merged companies & and hopefully synargistic effect of having a broader product mix available to the broadended distribution channels, I'm starting to wonder if the .15 FY98 EPS estimate might be pretty conservative. Thoughts? What a thought, a 114% EPS growth projection being conservative. Gotta love the potential here. Scott